CAMBRIDGE, Mass. (AP) _ Ironwood Pharmaceuticals Inc. (IRWD) on Wednesday reported a fourth-quarter loss of $15.5 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 10 cents. Losses, adjusted for non-recurring costs, came to 2 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The drugmaker posted revenue of $130.7 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $86.7 million.
For the year, the company reported that its loss widened to $282.4 million, or $1.85 per share. Revenue was reported as $346.6 million.
Ironwood expects full-year revenue in the range of $370 million to $390 million.
Ironwood shares have increased 28 percent since the beginning of the year. The stock has decreased nearly 5 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IRWD at https://www.zacks.com/ap/IRWD